• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成大麻素:在一个大型全球样本中与天然大麻相比的使用模式和效果特征比较。

Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample.

机构信息

South London and Maudsley NHS Trust/Kings College London, United Kingdom; Global Drug Survey, London, United Kingdom.

出版信息

Drug Alcohol Depend. 2013 Jul 1;131(1-2):106-11. doi: 10.1016/j.drugalcdep.2012.12.011. Epub 2013 Jan 3.

DOI:10.1016/j.drugalcdep.2012.12.011
PMID:23291209
Abstract

BACKGROUND

The last decade has seen the appearance of myriad novel psychoactive substances with diverse effect profiles. Synthetic cannabinoids are among the most recently identified but least researched of these substances.

METHODS

An anonymous online survey was conducted in 2011 using a quantitative structured research tool. Missing data (median 2%) were treated by available-case analysis.

RESULTS

Of 14,966 participants, 2513 (17%) reported use of synthetic cannabis. Of these, 980 (41% of 2417) reported its use in the last 12 months. Almost all recent synthetic cannabis users (99% of 975) reported ever use of natural cannabis. Synthetic cannabis reportedly had both a shorter duration of action (z=17.82, p<.001) and quicker time to peak onset of effect (z=-9.44, p<.001) than natural cannabis. Natural cannabis was preferred to synthetic cannabis by 93% of users, with natural cannabis rated as having greater pleasurable effects when high (t(930)=-37.1, p<.001, d=-1.22) and being more able to function after use (t(884)=-13.3, p<.001, d=-0.45). Synthetic cannabis was associated with more negative effects (t(859)=18.7, p<.001, d=0.64), hangover effects (t(854)=6.45, p<.001, d=0.22) and greater paranoia (t(889)=7.91, p<.001, d=0.27).

CONCLUSIONS

Users report a strong preference for natural over synthetic cannabis. The latter has a less desirable effect profile. Further research is required to determine longer term consequences of use and comparative dependence potential.

摘要

背景

过去十年出现了大量具有不同作用模式的新型精神活性物质。合成大麻素是最近发现的、但研究最少的物质之一。

方法

2011 年采用定量结构化研究工具进行了匿名在线调查。通过可用案例分析处理缺失数据(中位数 2%)。

结果

在 14966 名参与者中,2513 名(17%)报告使用合成大麻。其中,980 名(2417 名中的 41%)报告在过去 12 个月中使用过。几乎所有最近使用合成大麻的人(975 名中的 99%)都报告曾经使用过天然大麻。与天然大麻相比,合成大麻的作用持续时间更短(z=17.82,p<.001),作用峰值起效时间更快(z=-9.44,p<.001)。93%的使用者更喜欢天然大麻,与合成大麻相比,天然大麻在使用时感觉更愉快(t(930)=-37.1,p<.001,d=-1.22),使用后更能正常活动(t(884)=-13.3,p<.001,d=-0.45)。合成大麻与更多的不良影响有关(t(859)=18.7,p<.001,d=0.64),宿醉效应(t(854)=6.45,p<.001,d=0.22)和更高的偏执(t(889)=7.91,p<.001,d=0.27)。

结论

使用者报告说,他们强烈倾向于使用天然大麻而不是合成大麻。后者的作用模式不太理想。需要进一步研究以确定使用的长期后果和比较依赖性潜力。

相似文献

1
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample.合成大麻素:在一个大型全球样本中与天然大麻相比的使用模式和效果特征比较。
Drug Alcohol Depend. 2013 Jul 1;131(1-2):106-11. doi: 10.1016/j.drugalcdep.2012.12.011. Epub 2013 Jan 3.
2
The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.与使用合成大麻素产品相关的导致急诊就医的不良经历的12个月患病率及性质。
Hum Psychopharmacol. 2013 Jul;28(4):390-3. doi: 10.1002/hup.2292.
3
Patterns of synthetic cannabinoid use in Australia.澳大利亚合成大麻素使用模式。
Drug Alcohol Rev. 2013 Mar;32(2):141-6. doi: 10.1111/j.1465-3362.2012.00519.x. Epub 2012 Oct 9.
4
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.在一个全球大型样本中,食用大麻或合成大麻素后接受紧急医疗救治的风险。
J Psychopharmacol. 2015 Jun;29(6):698-703. doi: 10.1177/0269881115574493. Epub 2015 Mar 10.
5
Mental health differences between frequent cannabis users with and without dependence and the general population.频繁使用大麻且无依赖者与普通人群的心理健康差异。
Addiction. 2013 Aug;108(8):1459-69. doi: 10.1111/add.12196. Epub 2013 Apr 25.
6
Do police arrestees substitute legal highs for other drugs?被警方逮捕的人会用新型毒品替代其他毒品吗?
Int J Drug Policy. 2016 May;31:74-9. doi: 10.1016/j.drugpo.2016.01.006. Epub 2016 Jan 18.
7
[Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].[父母及社会影响对青少年非临床样本中大麻使用的作用]
Encephale. 2008 Jan;34(1):8-16. doi: 10.1016/j.encep.2007.01.002. Epub 2007 Sep 4.
8
[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].[门诊特定环境下大麻使用者的社会人口学特征、成瘾及精神共病情况]
Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19.
9
Growing medicine: small-scale cannabis cultivation for medical purposes in six different countries.种植药用大麻:六个不同国家小规模医用大麻种植。
Int J Drug Policy. 2015 Mar;26(3):250-6. doi: 10.1016/j.drugpo.2014.07.005. Epub 2014 Jul 21.
10
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users.睡眠障碍的药用大麻使用者对大麻品种和大麻素浓度的偏好
Addict Behav. 2015 Nov;50:178-81. doi: 10.1016/j.addbeh.2015.06.032. Epub 2015 Jun 23.

引用本文的文献

1
Synthetic cannabinoid use among noninstitutionalized individuals in the United States, 2021-2023.2021年至2023年美国非机构化人群中合成大麻素的使用情况。
Drug Alcohol Depend. 2025 May 1;270:112603. doi: 10.1016/j.drugalcdep.2025.112603. Epub 2025 Feb 12.
2
Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment.氯胺酮在全球大样本中的使用情况:特征、使用模式及紧急医疗处理
J Psychopharmacol. 2025 Jan;39(1):8-22. doi: 10.1177/02698811241273850. Epub 2024 Oct 17.
3
Interpreting mono- and poly-SCRA intoxications from an activity-based point of view: JWH-018 equivalents in serum as a comparative measure.
从基于活动的角度解读单一组分和多组分 SCRA 中毒:血清中 JWH-018 等效物作为比较指标。
Arch Toxicol. 2024 Oct;98(10):3337-3350. doi: 10.1007/s00204-024-03830-2. Epub 2024 Aug 8.
4
Over a third of treatment-seekers from São Paulo's Crackland report recent use of synthetic cannabinoids.来自圣保罗“可卡因之地”的超过三分之一的寻求治疗者报告称近期使用过合成大麻素。
Braz J Psychiatry. 2024;46:e20233234. doi: 10.47626/1516-4446-2023-3234. Epub 2024 Jun 21.
5
Synthetic Marijuana: Assessment of Usage, Motivation and Associated Risks in Adolescent Substance Users.合成大麻:青少年物质使用者的使用情况、动机及相关风险评估
Subst Use. 2024 May 17;18:29768357241254258. doi: 10.1177/29768357241254258. eCollection 2024 Jan-Dec.
6
Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists.新一代 OXIZID 合成大麻素受体激动剂的药理学评价。
Eur J Pharmacol. 2024 May 15;971:176549. doi: 10.1016/j.ejphar.2024.176549. Epub 2024 Mar 30.
7
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem.大麻作为获批药物的来源:老问题的新视角。
Molecules. 2023 Nov 21;28(23):7686. doi: 10.3390/molecules28237686.
8
A Descriptive Analysis of Adverse Event Reports from the Quebec Cannabis Registry.魁北克大麻登记处不良事件报告的描述性分析。
Drug Saf. 2024 Feb;47(2):161-171. doi: 10.1007/s40264-023-01379-0. Epub 2023 Nov 23.
9
The impact of cannabis legalization and decriminalization on acute poisoning: A systematic review.大麻合法化和非刑罪化对急性中毒的影响:系统评价。
Addiction. 2023 Dec;118(12):2252-2274. doi: 10.1111/add.16280. Epub 2023 Jul 26.
10
Mechanisms of cannabinoid tolerance.大麻素耐受的机制。
Biochem Pharmacol. 2023 Aug;214:115665. doi: 10.1016/j.bcp.2023.115665. Epub 2023 Jun 20.